Cargando…
Stem Cell Transplantation
Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121531/ http://dx.doi.org/10.1007/978-1-59745-415-5_8 |
_version_ | 1783515223236280320 |
---|---|
author | Wingard, John R. |
author_facet | Wingard, John R. |
author_sort | Wingard, John R. |
collection | PubMed |
description | Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant clinician are both myriad and dynamic. Early after transplant, neutropenic infections are most important. Later herpesvirus and invasive fungal infections predominate. Even late after transplant, patients with chronic graft versus host disease remain susceptible to encapsulated bacterial, varicella zoster virus, and invasive fungal infections. Over time, with robust engraftment and control of GVHD, the risk of serious infections recedes with immune reconstitution. |
format | Online Article Text |
id | pubmed-7121531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71215312020-04-06 Stem Cell Transplantation Wingard, John R. Managing Infections in Patients With Hematological Malignancies Article Hematopoietic cell transplantation (HCT) is associated with profound compromises in host defenses. The patterns of immune compromise change over time. Infections are an important cause of serious morbidity and pose substantial threats to life. Thus, the challenges of infection facing the transplant clinician are both myriad and dynamic. Early after transplant, neutropenic infections are most important. Later herpesvirus and invasive fungal infections predominate. Even late after transplant, patients with chronic graft versus host disease remain susceptible to encapsulated bacterial, varicella zoster virus, and invasive fungal infections. Over time, with robust engraftment and control of GVHD, the risk of serious infections recedes with immune reconstitution. 2009-08-31 /pmc/articles/PMC7121531/ http://dx.doi.org/10.1007/978-1-59745-415-5_8 Text en © Humana Press 2009 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Wingard, John R. Stem Cell Transplantation |
title | Stem Cell Transplantation |
title_full | Stem Cell Transplantation |
title_fullStr | Stem Cell Transplantation |
title_full_unstemmed | Stem Cell Transplantation |
title_short | Stem Cell Transplantation |
title_sort | stem cell transplantation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121531/ http://dx.doi.org/10.1007/978-1-59745-415-5_8 |
work_keys_str_mv | AT wingardjohnr stemcelltransplantation |